Targeted Delivery of Diphtheria Toxin into VEGFR1/VEGFR2 Overexpressing Cells Induces Anti-angiogenesis Activity.
Fatemeh Kazemi-LomedashtFarzad Taghizadeh-HesaryZahra FaalMahdi BehdaniPublished in: Current protein & peptide science (2024)
The developed TDT-triVGB3 is potentially a novel agent for targeting VEGFR1/ VEGFR2 over-expressing cancer cells.